209-847-2

应用筛选条件

关键词:'209-847-2'

显示 1-1 共 1 条结果关于 "209-847-2" 范围论文

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B.

Y Wang et al.

Journal of viral hepatitis, 20(4), e37-e46 (2013-03-16)

In the phase-III GLOBE/015 studies, telbivudine demonstrated superior efficacy vs lamivudine during 2-year treatment in HBeAg-positive and HBeAg-negative chronic hepatitis B (CHB). After completion, 847 patients had an option to continue telbivudine treatment for further 2 years. A total of

1/1